A Cross-Sectional Study of Tampering in Xtampza ER, an Abuse-Deterrent Formulation of an Extended-Release Opioid, in a Treatment Center Population

被引：0

作者：

Jennifer Jewell

Joshua Black

Matthew Ellis

Heather Olsen

Janetta Iwanicki

Richard Dart

机构：

[1] Denver Health and Hospital Authority,Rocky Mountain Poison and Drug Safety

[2] Washington University in St. Louis,Department of Psychiatry, School of Medicine

来源：

Clinical Drug Investigation | 2023年 / 43卷

关键词：

D O I：

暂无

中图分类号：

学科分类号：

摘要：

引用

页码：197 / 203

页数：6

共 38 条

[21] Human Abuse Potential of an Abuse-Deterrent (AD), Extended-Release (ER) Morphine Product Candidate (Morphine-ADER Injection-Molded Tablets) vs Extended-Release Morphine Administered Intranasally in Nondependent Recreational Opioid Users
Webster, Lynn R.
Smith, Michael D.
Lawler, John
Lindhardt, Karsten
Dayno, Jeffrey M.
PAIN MEDICINE, 2017, 18 (09) : 1695 - 1705
[22] Relative Oral Bioavailability of an Abuse-deterrent, Extended-release Formulation of Morphine Versus Extended-release Morphine: A 2-period, Single-dose, Randomized Crossover Study in Healthy Subjects
Kinzler, Eric R.
Pantaleon, Carmela
Aigner, Stefan
CLINICAL THERAPEUTICS, 2018, 40 (08) : 1357 - 1365
[23] Evaluation of the durability of pain relief throughout a 12 hour dosing interval of a novel, extended-release, abuse-deterrent formulation of oxycodone
Nalamachu, Srinivas
Kopecky, Ernest A.
Taylor, Robert, Jr.
Vaughn, Ben
O'Connor, Melinda
CURRENT MEDICAL RESEARCH AND OPINION, 2016, 32 (07) : 1311 - 1317
[24] Pharmacodynamic effects from a category 3 intranasal human abuse potential study of an abuse-deterrent, extended-release morphine product candidate in nondependent, recreational opioid users
Webster, L.
Smith, M.
Lawler, J.
Lindhardt, K.
Dayno, J.
JOURNAL OF PAIN, 2016, 17 (04): : S80 - S80
[25] A Randomized, Double-Blind, Double-Dummy Study to Evaluate the Intranasal Human Abuse Potential and Pharmacokinetics of a Novel Extended-Release Abuse-Deterrent Formulation of Oxycodone
Webster, Lynn R.
Kopecky, Ernest A.
Smith, Michael D.
Fleming, Alison B.
PAIN MEDICINE, 2016, 17 (06) : 1112 - 1130
[26] In response to Gudin et al. - Comparing the Effect of Tampering on the Oral Pharmacokinetic Profiles of Two Extended-Release Oxycodone Formulations with Abuse-Deterrent Properties
Crudele, Nancy T.
Giordano, Jennifer
Kapil, Ram P.
Randhawa, Amarita S.
PAIN MEDICINE, 2017, 18 (05) : 990 - 991
[27] An abuse-deterrent, microsphere-in-capsule formulation of extended-release oxycodone: alternative modes of administration to facilitate pain management in patients with dysphagia
McCarberg, Bill H.
Kopecky, Ernest A.
O'Connor, Melinda
Marseilles, Ann
Varanasi, Ravi K.
Thompson, Christy
Fleming, Alison B.
CURRENT MEDICAL RESEARCH AND OPINION, 2016, 32 (12) : 1975 - 1982
[28] The Potential Role of an Extended-Release, Abuse-Deterrent Oxycodone/Acetaminophen Fixed-Dose Combination Product for the Treatment of Acute Pain
Pergolizzi, Joseph V., Jr.
Taylor, Robert, Jr.
Raffa, Robert B.
ADVANCES IN THERAPY, 2015, 32 (06) : 485 - 495
[29] The Potential Role of an Extended-Release, Abuse-Deterrent Oxycodone/Acetaminophen Fixed-Dose Combination Product for the Treatment of Acute Pain
Joseph V. Pergolizzi
Robert Taylor
Robert B. Raffa
Advances in Therapy, 2015, 32 : 485 - 495
[30] Bioequivalence and food effect of a novel, abuse-deterrent (AD), extended-release (ER) morphine product candidate compared with a currently available non-AD, ER morphine product
Dayno, J.
Lawler, J.
Niebler, G.
Lindhardt, K.
JOURNAL OF PAIN, 2016, 17 (04): : S82 - S82

← 1 2 3 4 →